Variant report
Variant | nsv1055088 |
---|---|
Chromosome Location | chr14:38906586-38940508 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs567569527 | chr14:38910828-38910829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs536447560 | chr14:38910843-38910844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs556434591 | chr14:38910853-38910854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560997204 | chr14:38910916-38910917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs575791045 | chr14:38910932-38910933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs544717980 | chr14:38910952-38910953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs557990512 | chr14:38910956-38910957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs577930294 | chr14:38911004-38911005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs377130549 | chr14:38911026-38911027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs182000037 | chr14:38911043-38911044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs12890495 | chr14:38911058-38911059 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs185246027 | chr14:38911084-38911085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs79517487 | chr14:38911119-38911120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs189704157 | chr14:38911195-38911196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs531833919 | chr14:38911208-38911209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs145957158 | chr14:38911212-38911213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs117343752 | chr14:38911219-38911220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs180942498 | chr14:38911236-38911237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs547462015 | chr14:38911237-38911238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs7153963 | chr14:38911264-38911265 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs532180617 | chr14:38911274-38911275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536581655 | chr14:38911285-38911286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs4901867 | chr14:38911307-38911308 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs569802310 | chr14:38911309-38911310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs538468906 | chr14:38911348-38911349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558186451 | chr14:38911392-38911393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs114697068 | chr14:38911394-38911395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs533925994 | chr14:38911404-38911405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs553787831 | chr14:38911444-38911445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs542552335 | chr14:38911497-38911498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs186307311 | chr14:38911532-38911533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs113378587 | chr14:38911536-38911537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs562860070 | chr14:38911538-38911539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs183617437 | chr14:38911615-38911616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs368092661 | chr14:38911623-38911624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs188559849 | chr14:38911628-38911629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs139821578 | chr14:38911669-38911670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs34852967 | chr14:38911676-38911677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs527434790 | chr14:38911747-38911748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs565597186 | chr14:38911748-38911749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs143135989 | chr14:38911761-38911762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs192228957 | chr14:38911794-38911795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs142698223 | chr14:38914803-38914804 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
44 | rs531268704 | chr14:38914804-38914805 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550871200 | chr14:38914834-38914835 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
46 | rs577059795 | chr14:38914841-38914842 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
47 | rs564417106 | chr14:38914852-38914853 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
48 | rs550382858 | chr14:38914863-38914864 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
49 | rs374601948 | chr14:38914880-38914881 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
50 | rs112071080 | chr14:38914886-38914887 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Wilms tumour | 21544195 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 21298110 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Thyroid cancer | 19470727 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:38910800-38911600 | Enhancers | Fetal Heart | heart |
2 | chr14:38911400-38911800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr14:38914800-38916200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr14:38937000-38937200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr14:38937600-38937800 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr14:38937800-38944000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr14:38938200-38939800 | Enhancers | Muscle Satellite Cultured Cells | -- |